Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRize Circular Regulatory News (CIRC)

Share Price Information for Rize Circular (CIRC)

Share Price is delayed by 15 minutes
Get Live Data
472.40    0.00 (0.00%)
Bid:
473.55
Ask:
478.90
Spread: 5.35 (1.13%)
Market Cap: -
CIRC Live PriceLast checked at - London Stock Exchange

Intraday Rize Circular Share Chart

Additional Listing

28 Apr 2017 13:06

RNS Number : 7191D
Circle Holdings PLC
28 April 2017
 

 

Circle Holdings plc

("Circle" or the "Company")

 

Additional Listing

 

28 April 2017

 

As set out in the offer document published by DMWSL 849 Limited ("BidCo") on 4 April 2017 containing the full terms and conditions of a recommended all cash offer to be made by Bidco for all of the issued and to be issued share capital of Circle not already owned, or agreed to be acquired, by Bidco (the "Offer"), the Company announces that it has issued and allotted 2,905,181 ordinary shares of 2p each ("Ordinary Shares") conditionally upon their admission to AIM in respect of the exercise of the 2,200,000 CFO Options by Paolo Pieri and the issue of 705,181 Ordinary Shares to satisfy the corresponding subscription of Ordinary Shares by the Circle Trustee pursuant to the Circle Trust Relationship Agreement. Paolo Pieri and the Circle Trustee have agreed to accept the Offer in respect of these Ordinary Shares pursuant to the terms of the irrevocable undertakings they previously gave to BidCo. 

 

Accordingly, an application has been made for 2,905,181 new Ordinary Shares to be admitted to trading on AIM and it is expected that admission will take place on 2 May 2017.

 

The new Ordinary Shares will rank pari passu with the existing shares of the Company.

 

Following Admission, the Company's enlarged issued share capital will comprise 250,702,369 Ordinary Shares with one voting right per share. No shares are held in Treasury. The total number of voting rights in the Company is therefore 250,702,369.

 

This figure of 250,702,369 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

For further information, please contact:

 

Circle Holdings plc +44 (0)20 7034 5258

Michael Kirkwood, ChairmanPaolo Pieri, Chief Executive Officer

Alex Singleton, Head of Communications and Marketing

 

Numis Securities Limited +44 (0)20 7260 1000

Michael Meade, Richard Thomas Nominated Adviser

Ben Stoop Corporate Broking

 

About Circle

 

Established in 2004, Circle Holdings plc is an employee co-owned group dedicating to empowering clinicians and healthcare professionals to redefine the delivery of healthcare in the UK. Circle's NHS and independent healthcare operations include two independent hospitals, Circle Bath and Circle Reading, the Nottingham NHS Treatment Centre, and the management of integrated musculoskeletal (MSK) services on behalf of local commissioners in Bedfordshire and Greenwich. Circle is currently building its latest state-of-the-art independent hospital in Birmingham.

 

For more information please visit www.circleholdingsplc.com and www.circlehealth.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ALSGMGZDZRKGNZM
Date   Source Headline
12th May 20173:17 pmRNSHolding(s) in Company
3rd May 20172:17 pmRNSRule 2.9 Announcement
3rd May 201710:26 amRNSHolding(s) in Company
3rd May 20177:00 amRNSBidco Compulsory Acquisition of Circle Shares
3rd May 20177:00 amRNSProposed cancellation of trading on AIM
28th Apr 20171:06 pmRNSAdditional Listing
27th Apr 20179:08 amRNSHolding(s) in Company
26th Apr 20177:00 amRNSDMWSL 849 Limited - Offer Unconditional
20th Apr 20173:20 pmRNSForm 8.3 - Circle Holdings Plc
13th Apr 201712:37 pmRNSForm 8.3 - Circle Holdings PLC
11th Apr 20179:38 amRNSForm 8.3 - CIRCLE HOLDINGS PLC
10th Apr 20178:45 amRNSForm 8.5 (EPT/RI) - Circle Holdings Plc
6th Apr 20174:01 pmRNSForm 8 (OPD) Circle Holdings plc
6th Apr 20174:00 pmRNSRule 2.9 Announcement
5th Apr 201710:41 amRNSForm 8.3 - CIRCLE HOLDINGS PLC
4th Apr 20175:29 pmRNSHolding(s) in Company
4th Apr 20174:15 pmRNSForm 8.3 - Circle Holdings plc
4th Apr 20172:03 pmRNSForm 8.3 - Circle Holdings Plc
4th Apr 20171:30 pmRNSOffer Document Posted
4th Apr 20171:30 pmRNSDMWSL 849 Limited - Offer Document Published
4th Apr 20179:25 amRNSForm 8.3 - Circle Holdings PLC
4th Apr 20177:00 amRNSContract
3rd Apr 20173:20 pmRNSForm 8.3 - Circle Holdings Plc
31st Mar 20179:37 amRNSForm 8.3 -CIRCLE HOLDINGS PLC
30th Mar 20173:20 pmRNSForm 8.3 - Circle Holdings Plc
30th Mar 201712:31 pmRNSHolding(s) in Company
30th Mar 201712:27 pmRNSHolding(s) in Company
30th Mar 201712:16 pmRNSForm 8.3 - Circle Holdings Plc
30th Mar 201711:28 amRNSForm 8.3 - Circle Holdings plc
30th Mar 201710:30 amRNSForm 8 (DD) - DMWSL 849 Limited / Circle Holdings
30th Mar 201710:30 amRNSForm 8 (DD) - Circle Holdings plc
30th Mar 20179:51 amRNSForm 8.3 - Circle Holdings PLC
29th Mar 20179:46 amRNSForm 8 (OPD) DMWSL 849 Limited
29th Mar 20177:02 amRNSRecommended Cash Offer for Circle Holdings plc
29th Mar 20177:01 amRNSRule 2.7 Announcement: Recommended cash offer
29th Mar 20177:00 amRNSFull Year 2016 Audited Results
28th Mar 20174:40 pmRNSSecond Price Monitoring Extn
28th Mar 20174:35 pmRNSPrice Monitoring Extension
24th Mar 20175:19 pmRNSContract
23rd Feb 20174:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20174:35 pmRNSPrice Monitoring Extension
1st Feb 20174:35 pmRNSPrice Monitoring Extension
1st Feb 20177:00 amRNSDisposal
23rd Dec 20167:00 amRNSJoint Venture
2nd Dec 20164:40 pmRNSSecond Price Monitoring Extn
2nd Dec 20164:35 pmRNSPrice Monitoring Extension
28th Nov 20167:00 amRNSDirectorate Change
16th Sep 20169:50 amRNSIssue of Share Options to PDMR
12th Sep 20163:24 pmRNSHolding(s) in Company
9th Sep 20162:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.